225 related articles for article (PubMed ID: 25880088)
1. BCL-2 is dispensable for thrombopoiesis and platelet survival.
Debrincat MA; Pleines I; Lebois M; Lane RM; Holmes ML; Corbin J; Vandenberg CJ; Alexander WS; Ng AP; Strasser A; Bouillet P; Sola-Visner M; Kile BT; Josefsson EC
Cell Death Dis; 2015 Apr; 6(4):e1721. PubMed ID: 25880088
[TBL] [Abstract][Full Text] [Related]
2. Mcl-1 and Bcl-x(L) coordinately regulate megakaryocyte survival.
Debrincat MA; Josefsson EC; James C; Henley KJ; Ellis S; Lebois M; Betterman KL; Lane RM; Rogers KL; White MJ; Roberts AW; Harvey NL; Metcalf D; Kile BT
Blood; 2012 Jun; 119(24):5850-8. PubMed ID: 22374700
[TBL] [Abstract][Full Text] [Related]
3. Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan.
Liu ZJ; Hoffmeister KM; Hu Z; Mager DE; Ait-Oudhia S; Debrincat MA; Pleines I; Josefsson EC; Kile BT; Italiano J; Ramsey H; Grozovsky R; Veng-Pedersen P; Chavda C; Sola-Visner M
Blood; 2014 May; 123(22):3381-9. PubMed ID: 24599546
[TBL] [Abstract][Full Text] [Related]
4. BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation.
Vogler M; Hamali HA; Sun XM; Bampton ET; Dinsdale D; Snowden RT; Dyer MJ; Goodall AH; Cohen GM
Blood; 2011 Jun; 117(26):7145-54. PubMed ID: 21562047
[TBL] [Abstract][Full Text] [Related]
5. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets.
Kodama T; Takehara T; Hikita H; Shimizu S; Shigekawa M; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Yin XM; Hayashi N
J Biol Chem; 2011 Apr; 286(16):13905-13. PubMed ID: 21367852
[TBL] [Abstract][Full Text] [Related]
6. Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages.
Kodama T; Hikita H; Kawaguchi T; Shigekawa M; Shimizu S; Hayashi Y; Li W; Miyagi T; Hosui A; Tatsumi T; Kanto T; Hiramatsu N; Kiyomizu K; Tadokoro S; Tomiyama Y; Hayashi N; Takehara T
Cell Death Differ; 2012 Nov; 19(11):1856-69. PubMed ID: 22790873
[TBL] [Abstract][Full Text] [Related]
7. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function.
White MJ; Schoenwaelder SM; Josefsson EC; Jarman KE; Henley KJ; James C; Debrincat MA; Jackson SP; Huang DC; Kile BT
Blood; 2012 May; 119(18):4283-90. PubMed ID: 22294729
[TBL] [Abstract][Full Text] [Related]
8. The role of apoptosis in megakaryocytes and platelets.
Kile BT
Br J Haematol; 2014 Apr; 165(2):217-26. PubMed ID: 24467740
[TBL] [Abstract][Full Text] [Related]
9. In non-transformed cells Bak activates upon loss of anti-apoptotic Bcl-XL and Mcl-1 but in the absence of active BH3-only proteins.
Senft D; Weber A; Saathoff F; Berking C; Heppt MV; Kammerbauer C; Rothenfusser S; Kellner S; Kurgyis Z; Besch R; Häcker G
Cell Death Dis; 2015 Nov; 6(11):e1996. PubMed ID: 26610208
[TBL] [Abstract][Full Text] [Related]
10. Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways.
Josefsson EC; Burnett DL; Lebois M; Debrincat MA; White MJ; Henley KJ; Lane RM; Moujalled D; Preston SP; O'Reilly LA; Pellegrini M; Metcalf D; Strasser A; Kile BT
Nat Commun; 2014 Mar; 5():3455. PubMed ID: 24632563
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Platelet Production and Life Span: Role of Bcl-xL and Potential Implications for Human Platelet Diseases.
Josefsson EC; Vainchenker W; James C
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066573
[TBL] [Abstract][Full Text] [Related]
12. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
[TBL] [Abstract][Full Text] [Related]
13. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.
Tanos R; Karmali D; Nalluri S; Goldsmith KC
BMC Cancer; 2016 Feb; 16():97. PubMed ID: 26874859
[TBL] [Abstract][Full Text] [Related]
14. Loss of PUMA (BBC3) does not prevent thrombocytopenia caused by the loss of BCL-XL (BCL2L1).
Delbridge AR; Chappaz S; Ritchie ME; Kile BT; Strasser A; Grabow S
Br J Haematol; 2016 Sep; 174(6):962-9. PubMed ID: 27221652
[TBL] [Abstract][Full Text] [Related]
15. Loss of Bak enhances lymphocytosis but does not ameliorate thrombocytopaenia in BCL-2 transgenic mice.
Vandenberg CJ; Josefsson EC; Campbell KJ; James C; Lawlor KE; Kile BT; Cory S
Cell Death Differ; 2014 May; 21(5):676-84. PubMed ID: 24464220
[TBL] [Abstract][Full Text] [Related]
16. ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia.
Vandenberg CJ; Cory S
Blood; 2013 Mar; 121(12):2285-8. PubMed ID: 23341542
[TBL] [Abstract][Full Text] [Related]
17. Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy.
Leverson JD; Phillips DC; Mitten MJ; Boghaert ER; Diaz D; Tahir SK; Belmont LD; Nimmer P; Xiao Y; Ma XM; Lowes KN; Kovar P; Chen J; Jin S; Smith M; Xue J; Zhang H; Oleksijew A; Magoc TJ; Vaidya KS; Albert DH; Tarrant JM; La N; Wang L; Tao ZF; Wendt MD; Sampath D; Rosenberg SH; Tse C; Huang DC; Fairbrother WJ; Elmore SW; Souers AJ
Sci Transl Med; 2015 Mar; 7(279):279ra40. PubMed ID: 25787766
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets.
Schoenwaelder SM; Jarman KE; Gardiner EE; Hua M; Qiao J; White MJ; Josefsson EC; Alwis I; Ono A; Willcox A; Andrews RK; Mason KD; Salem HH; Huang DC; Kile BT; Roberts AW; Jackson SP
Blood; 2011 Aug; 118(6):1663-74. PubMed ID: 21673344
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival.
Eichhorn JM; Alford SE; Sakurikar N; Chambers TC
Exp Cell Res; 2014 Apr; 322(2):415-24. PubMed ID: 24556425
[TBL] [Abstract][Full Text] [Related]
20. The role of platelet factor 4 in radiation-induced thrombocytopenia.
Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
